In liver carcinoma cells, PAR2 triggers transactivation of the tyrosine kinase receptor, Met, to promote cell migration and invasion [54,55] and exhibits signalling crosstalk with the PDGFR to induce phosphorylation and activation of the PDGFR [53]. The gene discussed is PDGFRB; the disease is hepatocellular carcinoma.